Effective Communication is Necessary for Pathologists to Make Accurate Diagnoses

Commentary
Video

In community settings, offices may have to send pathology specimens to reference labs, and it may be difficult to maintain effective communication.

Generally, the communication in academic oncology institutions is favorable; however, when oncologists and pathologists become busy, specimens may be sent to reference laboratories. When that happens, and a reference laboratory pathologist is examining 200 to 300 specimens a day, ranging from surgical pathology specimens to bone marrow biopsies, there isn’t enough time to effectively communicate with each physician regarding each patient.

During the Society of Hematologic Oncology 2025 Annual Meeting, CancerNetwork® spoke with Sanam Loghavi, MD, following a discussion titled “The Evolving Landscape of Anemia in MDS & MPNs: Clinical Updates and Best Practices” where she was a panel member.

During the interview, Loghavi emphasized the importance of following specific protocols, such as filling out requisition sheets and patient history, to ensure that correct and complete data gets to the pathologist so they can make an accurate diagnosis as quickly as possible.

Loghavi is an assistant professor in the Department of Hematopathology in the Division of Pathology and Lab Medicine at the University of Texas MD Anderson Cancer Center.

Transcript:

In the academic centers, the communication is good. Where the problem may exist [is that] in pathology in general, a lot of practices are reference labs. A lot of community practice oncology offices may send their specimens to reference labs, and the reason is mostly because people are very busy. If I’m a pathologist who’s practicing at a reference lab, and I have to see 200 to 300 cases a day, that’s a mixture of surgical pathology specimens, [gastrointestinal] biopsies, and bone marrow biopsies. First of all, there’s no time to be able to effectively communicate about every sample with every physician. What would be helpful for that type of practice, which is for sure one of the more common types of practices, is for the clinicians to provide the pathologists with the necessary information that enables them to make an accurate diagnosis. The requisition sheet, the [patient] history, or however that information is conveyed to the pathologist, should hopefully be as complete as possible to equip them to be able to make an accurate diagnosis.

Recent Videos
Factors like genetic mutations and smoking may represent red flags in pancreatic cancer detection, said Jose G. Trevino, II, MD, FACS.
Insurance and distance to a tertiary cancer center were 2 barriers to receiving high-quality breast cancer care, according to Rachel Greenup, MD, MPH.
Numerous clinical trials vindicating the addition of immunotherapy to first-line chemotherapy in SCLC have emerged over the last several years.
According to John Henson, MD, “What we need are better treatments to control the [brain] tumor once it’s detected.”
First-degree relatives of patients who passed away from pancreatic cancer should be genetically tested to identify their risk for the disease.
Surgery and radiation chemotherapy can affect immunotherapy’s ability to target tumor cells in the nervous system, according to John Henson, MD.
Thinking about how to sequence additional agents following targeted therapy may be a key consideration in the future of lung cancer care.
Endobronchial ultrasound, robotic bronchoscopy, or other expensive procedures may exacerbate financial toxicity for patients seeking lung cancer care.
Destigmatizing cancer care for incarcerated patients may help ensure that they feel supported both in their treatment and their humanity.
Patients with mediastinal lymph node involved-lung cancer may benefit from chemoimmunotherapy in the neoadjuvant setting.
Related Content